Phathom Pharmaceuticals (PHAT) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to -$3.0 million.
- Phathom Pharmaceuticals' Other Gross PP&E Adjustments fell 24722.63% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 24722.63%. This contributed to the annual value of $2.5 million for FY2024, which is 16437.63% up from last year.
- Phathom Pharmaceuticals' Other Gross PP&E Adjustments amounted to -$3.0 million in Q3 2025, which was down 24722.63% from -$1.0 million recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' Other Gross PP&E Adjustments ranged from a high of $2.5 million in Q4 2024 and a low of -$4.8 million during Q2 2022
- Over the past 4 years, Phathom Pharmaceuticals' median Other Gross PP&E Adjustments value was -$1.0 million (recorded in 2025), while the average stood at -$854666.7.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first skyrocketed by 39607.56% in 2024, then plummeted by 24722.63% in 2025.
- Phathom Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$2.6 million in 2022, then skyrocketed by 136.26% to $946000.0 in 2023, then surged by 164.38% to $2.5 million in 2024, then crashed by 219.91% to -$3.0 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$3.0 million for Q3 2025, versus -$1.0 million for Q2 2025 and -$1.0 million for Q1 2025.